Jon Hartman

1K posts

Jon Hartman

Jon Hartman

@JonHartman14

Managing Partner, HBCM. Ex-Oppenheimer Funds Global Equities.

United States Katılım Aralık 2015
681 Takip Edilen491 Takipçiler
Sid Prabhu
Sid Prabhu@sidprabhu·
Global Savings Shortage™
Sid Prabhu tweet media
English
1
1
18
1.6K
Jon Hartman retweetledi
Jon Hartman
Jon Hartman@JonHartman14·
@sidprabhu Setting up for a Liz Truss moment
English
0
1
0
273
Jon Hartman
Jon Hartman@JonHartman14·
@sama You should stop going on podcasts and pontificating about economics. It is not helping.
English
0
0
3
42
Sam Altman
Sam Altman@sama·
chatgpt has gotten soooo much better with the latest update. really proud of the team for this one.
English
2.5K
563
15.8K
1.4M
Max Schatzow
Max Schatzow@AdviserCounsel·
Can someone explain to me how shares are priced at $185 in an IPO and immediately trade at $350? Yes, this is a Cerebras tweet. Also, IPOs are back???!!!
English
4
0
1
1.7K
Jon Hartman
Jon Hartman@JonHartman14·
@viggy_krishnan @TheLAPurchaser Ten years ago A&G was 60% of business. It is now <40%. Most recent Q was +20% / -13% clinical / A&G. A&G will be <25% of consumables biz in a few years. Overall growth rate will slowly converge to clinical growth rate as mix continues to change.
English
0
0
1
53
TheLAPurchaser
TheLAPurchaser@TheLAPurchaser·
Alright anyone own $ILMN on the CEO in Beijing trade? What’re you hoping for?
English
4
0
9
5.2K
Jon Hartman
Jon Hartman@JonHartman14·
I find myself repeating "Don't cut the flowers to water the weeds." Easier said than done.
English
0
1
2
179
Jon Hartman
Jon Hartman@JonHartman14·
@viggy_krishnan @LongVollllll Medtech slowly comping its elective procedure backlog has been painful. Amazing the multiple has compressed by 10pts for a 2% revenue deceleration.
English
0
0
1
45
FestivusCap
FestivusCap@LongVollllll·
The non-biotech healthcare move over the past year is way worse then GLP-1 in 23 because I don't even know what ghost I'm fighting
English
6
0
47
6.7K
Jon Hartman
Jon Hartman@JonHartman14·
@RagingVentures Going to be lots of strategic double ordering as companies fear not getting adequate allocation of incremental wafer starts.
English
0
0
0
218
Jon Hartman
Jon Hartman@JonHartman14·
@ErnestWongBWM Tough to pay >2x market multiple (not anymore) for a company making a material tech transition that could threaten what made the brand so impenetrable.
English
0
0
0
48
Ernest Wong
Ernest Wong@ErnestWongBWM·
Demand for an EV Ferrari aside, Ferrari registered for the upcoming Luce "60 patents from electric engines to inverters, vehicle dynamics, battery integration, steering wheel, glass windows, and wipers"
English
1
0
9
1.2K
TheLAPurchaser
TheLAPurchaser@TheLAPurchaser·
$WAT - Udit putting some life in life sciences
GIF
English
1
1
21
2.5K
Jon Hartman
Jon Hartman@JonHartman14·
@GavinSBaker Hugh Johnston. Beat earnings 54 of 55 quarters at Pepsi. Pushed out his retirement to financially restore Disney. FCF is up 10x from 2022 (record FCF in 2025), reinstated dividend and buyback. Stock performance notwithstanding, he has done an excellent job fixing Disney.
English
0
0
0
477
Gavin Baker
Gavin Baker@GavinSBaker·
Sarah is a Hall of Fame CFO. Right up there with Colette Kress, David Zinsner and Amy Hood. Susan Li might join the club, early but off to an epic start. Who am I missing? This was off the cuff. wsj.com/business/opena…
English
52
7
288
95.1K
Jon Hartman
Jon Hartman@JonHartman14·
@viggy_krishnan @evrgn11112231 Not necessarily. They have 1.5-2GW which is the result of 2025 planning decisions. I dont think they planned for remotely close to 45bn last year. Ofc if they are doing 500bn of revs all bets are off, margins will be high. I'd be shocked if non-adjusted GMs are >50% LT.
English
0
0
1
34